Related references
Note: Only part of the references are listed.The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
Adam L. Boxer et al.
ALZHEIMERS & DEMENTIA (2013)
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Maria Landqvist Waldo et al.
BMC NEUROLOGY (2013)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
Jennifer L. Whitwell et al.
BRAIN (2012)
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
R. Tortelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Clinicopathological Correlations in Corticobasal Degeneration
Suzee E. Lee et al.
ANNALS OF NEUROLOGY (2011)
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family
Adam L. Boxer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
G. D. Rabinovici et al.
NEUROLOGY (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
Alzheimer's disease: progress in prediction
Ronald C. Petersen
LANCET NEUROLOGY (2010)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia
William W. Seeley et al.
ARCHIVES OF NEUROLOGY (2008)
CSF biomarkers in frontotemporal lobar degeneration with known pathology
H. Bian et al.
NEUROLOGY (2008)
CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease
W. Farid Abdo et al.
NEUROBIOLOGY OF AGING (2007)
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls
Yolande A. L. Pijnenburg et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
The pathological basis of semantic dementia
RR Davies et al.
BRAIN (2005)
Clinical characteristics in early Parkinson's disease in a Central California population-based study
GA Kang et al.
MOVEMENT DISORDERS (2005)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Voxel-based morphometry of the human brain: Methods and applications
A Mechelli et al.
CURRENT MEDICAL IMAGING (2005)
Amyloid β(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease
NSM Schoonenboom et al.
NEUROLOGY (2004)
Elevated neurofilament levels in neurological
N Norgren et al.
BRAIN RESEARCH (2003)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Tau and Aβ42 protein in CSF of patients with frontotemporal degeneration
M Riemenschneider et al.
NEUROLOGY (2002)
Tau protein in cerebrospinal fluid from semantic dementia patients
C Andersen et al.
NEUROSCIENCE LETTERS (2000)
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
M Sjögren et al.
NEUROLOGY (2000)
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
M Sjogren et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Alzheimer's disease and its focal variants
JH Kramer et al.
SEMINARS IN NEUROLOGY (2000)
Share Paper
